Here's my honest review Kate Moss is the face of this just-launched mascara that promises a 'double lash effect' - and I put the latest formula to the test Shoppers are raving about 'pain-free' £ ...

In light of these developments, Molecular Templates has cautioned that trading in its securities is highly speculative and carries substantial risks. InvestingPro analysis reveals the company is ...

Molecular Templates, Inc. (NASDAQ ... analysis reveals the company is quickly burning through cash with a negative free cash flow yield, adding to investor concerns. The company has warned that ...

Molecular Templates, Inc., a clinical-stage biopharmaceutical company focused on developing cancer therapies, has been informed by Nasdaq that it is deemed a "public shell" and its continuation on ...